MBMR Biolabs is a biotechnology startup founded in 2010 that specializes in harnessing the power of biocompatible tetrazine cycloaddition. Their slogan, "Harnessing the power of biocompatible tetrazine cycloaddition to pursue advanced imaging and molecular retrieval across diverse biological systems," encapsulates their core focus. The company has developed applications that leverage tetrazine cycloaddition to image and retrieve nucleic acids, proteins, glycans, lipids, and other metabolites in vitro, in cells, and in whole organisms.
MBMR Biolabs received a $499.82K grant investment on 22nd March 2012 from the National Science Foundation. This funding has provided the necessary support for the company's research and development efforts.
This innovative approach aligns with the growing demand for advanced imaging and molecular retrieval techniques in the biotechnology industry, positioning MBMR Biolabs as a promising player in the field. The ability to apply their technology across diverse biological systems further enhances their potential impact. With the support of the National Science Foundation, MBMR Biolabs is well-positioned to continue its pioneering work in biocompatible tetrazine cycloaddition.
